Kathleen Sereda Glaub
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Kathleen Sereda Glaub
Kathleen Sereda Glaub was last confirmed as Board Member at Aligos Therapeutics, Inc. (ALGS) in a filing dated April 27, 2021. Earlier roles on record: Board Member at IO Biotech, Inc. (IOBTQ) until March 31, 2026. IO Biotech, Inc. reported in an 8-K filed March 31, 2026 that Kathleen Sereda Glaub resigned as Board of Directors, effective March 31, 2026.
“Concurrently with the Petition, on March 31, 2026, each member of the Company's board of directors, Peter Hirth, Helen Collins, Christian Elling, Kathleen Glaub, Heidi Hunter and David Smith, resigned from the Board of Directors of the Company and all of its committees.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2018-01-01–2026-03-31
-
Start not stated–2021-04-27
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.